I've owned NVIV for over three years so I'd hardly say that I've traded the stock. As an investor in the company, I have every right to gripe, complain and #$%$ as much as I want to when the share price is down 50% from recent highs!!!!
The Dow is up almost 900 points in the last two trading sessions and NVIV is one of 5 or 6 stocks of over 100 that I follow that are in the red today. And that’s after almost a 50% plunge from recent highs. Has to be a negative out there that we are unaware of! Something ain’t right in Dodge City!
One of the most difficult elements of investing has to do with divorcing ourselves from the "story." I'm not saying that NVIV won't eventually become a very successful company but I can tell you that over my some odd 40 years of investing that EVERY time I've paid more attention to the story rather than the technicals - it has always cost me a lot of money. Since last June, NVIV has issued five different sell signals. In late June it issued its first sell signal when it closed below the 9-Day Moving Average around $17. The most recent sell signal was generated yesterday when NVIV closed below its 200-DMA which is most always a bearish indicator. You'll drive yourself crazy if you try to rationalize why this is all happening. The main takeaway from the decline in NVIV is that if you take sell signals for what they are and sell the stock, it will most always save you a lot of money and isn't that why we are all investors? We all want to try our best to maximize our profits and limit our losses. Adhering to technical analysis will help you accomplish these goals.
Let's all forget about the fundamentals for a second, as everything we have seen to date, everything that has been reported to date, indicates the fundamentals are strong. However, technically speaking, we are dealing with a broken stock. With the exception of a couple days ago - literally every day for the last three weeks - NVIV has traded lower - not just a little lower but almost every day it has set a newer low - just like today. I don't know what it is going to take to turn this stock around, particularly in a declining market but before it happens, we're probably headed to single digits.Today's close was the lowest close for NVIV since March 19 - not a good indication that we're headed higher any time soon!!
Look - any time anyone says anything negative (and I really haven't said anything negative - I've just stated the facts), for some reason it's construed as bashing. I'm long NVIV but extremely frustrated with the fact that it's down 40% from its recent high.
"Mike hasn't been around for a while" Did you ever consider the fact he got smart and sold his shares? How the frick do you expect everybody to settle down when NVIV has been plunging - down literally every day for the last three weeks - every day setting a lower low. No one can relax under these circumstances. News probably won't even matter any more.
Problem was it never made a breakout above $18 - then a double bottom sell signal came when it closed below $14.50 and it's done nothing but go down since the sell signal when it closed below $14.50. Like I said - management needs to step it up!
What many of us longs on this board thought was the "Holy Grail" of SCI has turned into a disaster. Now down 40% for its high less than two months, it's way past time for management to deliver some news to keep our ship from officially sinking!
Not sure your thesis has any validity. If you buy or sell 2k shares at the market, the order will get filled in 100 share lots.
I hope Fidelity is right but I doubt it.Based on long, medium and short-term indicators, BarChart has NVIV rated a sell. StockTA has all but one indicator as bearish the other is neutral. NVIV has been down every day for the last three weeks - this is much more than just a normal correction. Makes investors think there's something seriously wrong so management better get their act together and produce some very positive news on Monday.
Getting very old. No matter how much you believe in the company you can only take so much and stick around so long when you're losing money every friggin day!
yep been following NVIV for over 3 years. Our newsletter - Market Digest Online - has been recommending the stock since $2 three years ago. When it hit $6 we advised selling based on the Frank Reynolds fiasco and then re-recommended last October at $.50. NVIV is currently stuck in the mud because of negative timing. Looking for it to hopefully come back to life next week. While NVIV has great potential, AVXL has a much greater potential with the ability to come to commercialization much sooner than NVIV.
Sentiment: Strong Buy
Something very big is going on here. Do not let them steal your shares! Now up 36% off this morning's low - extremely bullish price action. AVXL going much, much higher!! Stay long and stay strong. All dips should be bought!!
I see the drug can be purchased but how? Thought this was still in trials. Pretty expensive - a 10mg dose is $165 while 50mg sells for $695. Can anyone explain this?
Sentiment: Strong Buy
Aricept is manufactured by a Japanese company by the name of Eisai and Eisai is partnered with Pfizer. In 2013 sales of Aricept was a whopping $97 billion yen. If trials continue to confirm that Anavex's drug, Anavex 2-73, is four times better than Aricept, something is way out of kilter here with AVXL's total market cap closing at $70 million on Friday!!
Sentiment: Strong Buy
direct costs to American society of caring for those with Alzheimer's will total an estimated $226 billion, with half of the costs borne by Medicare.
Needless to say, AVXL has performed well after last week's reporting of positive results of the company's drug trial of Anavex 2-73 in patients with Alzheimer's disease. Reports that the company's drug improved electrical markers by four times more than the current standard of care drug, which is a medication called donepezil (Aricept), sent the stock soaring. In 2015, the direct costs to American society of caring for those with Alzheimer's will total an estimated $226 BILLION, with half of those costs borne by Medicare. The implications could be huge here if Anavex's drug is indeed four times better than anything currently available to Alzheimer's patients. If these reports are indeed true, and none of us should have any reason to doubt them, seems shares of AVXL should be trading much higher than penny stock status. After a dip to $.7345 earlier this morning, the stock seems to be finding legs here and for speculators, this dip offers a better entry point 25% cheaper than yesterday's high. If you don't buy here, you will soon be paying well north of the $1.00 level.
Sentiment: Strong Buy
This is now the second time in the last three weeks we've literally had the rug pulled out from under us. This crazy volatility is almost becoming too much to handle - NVIV is definitely not for the faint of heart!